Five isolated xanthones from the C. cochinchinense and G. mangostana were evaluated and tested for antibacterial activities. Isolated 4 and 5 exhibited potent anti-MRSA and P. aeruginosa activity, but showed poor pharmacokinetic properties via ADMET prediction. It led us to improve pharmacokinetic properties of 4 and 5 by partially modifying them in acidic condition yielding fourteen analogues. It was found that analogues 4b, 4d and 5b possessed proper pharmacokinetic properties, while only 4b exhibited the best anti-MRSA and P. aeruginosa activity. The SEM results indicated that 4b may interact with or damage the cell wall of MRSA and P. aeruginosa. Moreover, a combination of 4b and vancomycin exhibits synergistic effect against both MRSA and P. aeruginosa at MIC value of 4.98 (MIC = 18.75 μg/mL for 4b) and 9.52 μg/mL (MIC = 75 μg/mL for 4b), respectively.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2020.127494 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluating racial and ethnic disparities in antibiotic treatment for pneumonia patients in a major academic health system.
Antimicrob Steward Healthc Epidemiol
December 2024
Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Atlanta, GA, USA.
Objective: Examine the relationship between patients' race and prescriber antibiotic choice while accounting for differences in underlying illness and infection severity.
Design: Retrospective cohort analysis.
Setting: Acute care facilities within an academic healthcare system.
Effective tailoring of cefepime into bilosomes: A promising nanoplatform for enhancing oral absorption, extending half-life, and evaluating biocompatibility, antibacterial, anti-biofilm, anti-breast cancer activity, ex-vivo, and in-vivo studies.
Int J Pharm
January 2025
Department of Pharmaceutics, Faculty of Pharmacy, Port Said University, Port Said 42515, Egypt. Electronic address:
Article Synopsis
- Cefepime HCl has low oral bioavailability and adverse effects, leading to the need for a better delivery system since there is currently no approved oral form.
- The study introduces a novel sustained-release oral delivery method using bilosomes that enhances the drug's loading efficiency and extends its half-life.
- The optimal formulation, B3, shows promising results with improved bioavailability and antimicrobial activity against various bacteria compared to pure cefepime.
Clarithromycin-tailored cubosome: A sustained release oral nano platform for evaluating antibacterial, anti-biofilm, anti-inflammatory, anti-liver cancer, biocompatibility, ex-vivo and in-vivo studies.
Int J Pharm
December 2024
Department of Pharmaceutics, Faculty of Pharmacy, Port Said University, Port Said 42515, Egypt. Electronic address:
The clinical implication of clarithromycin (CLT) is compromised owing to its poor solubility and, subsequently, bioavailability, unpalatable taste, rapid metabolism, short half-life, frequent dosing, and adverse effects. The present investigation provides an innovative sustained-release oral drug delivery strategy that tackles these challenges. Accordingly, CLT was loaded into a cubosome, a vesicular system with a bicontinuous cubic structure that promotes solubility and bioavailability, provides a sustained release system combating short half-life and adverse effects, masks unpleasant taste, and protects the drug from destruction in gastrointestinal tract (GIT).
View Article and Find Full Text PDFN-acyl-4-arylaminopiperidines: Design and synthesis of a potential antimicrobial scaffold.
Bioorg Med Chem Lett
November 2024
Departmento de Química Orgánica. Instituto de Química, Universidad Nacional Autónoma de México, Mexico.
We report a concise synthesis of N-acylated piperidines through a Knoevenagel-Doebner condensation/amide construction/ amination sequence. The design of the piperidines considered the pharmacophoric features found in previously reported inhibitors of FabI, an enzyme implicated in bacterial fatty acid biosynthesis. After the microbiological evaluation at 50 μM, the analogs displayed moderate activity against some pathogens from the ESKAPE group, reaching up to 42 % of growth inhibition for MRSA, 54 % for K.
View Article and Find Full Text PDFAnti-MRSA activity of chlorophenyl pyrrolo benzodiazepines compound.
J Antibiot (Tokyo)
September 2024
Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, 721302, WB, India.
Antibiotic resistant is the major concern in public health to control the infectious diseases. MRSA (Methicillin-resistant Staphylococcus aureus) is a significant concern in healthcare settings due to its resistance to many antibiotics, including methicillin and other beta-lactams. MRSA infection difficult to treat and increases the risk of complications.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!